SEPTOCAINE

Septocaine Adverse Events Reported to the FDA Over Time

How are Septocaine adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Septocaine, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Septocaine is flagged as the suspect drug causing the adverse event.

Most Common Septocaine Adverse Events Reported to the FDA

What are the most common Septocaine adverse events reported to the FDA?

Hypoaesthesia Oral	60 (6.05%)
Paraesthesia	56 (5.65%)
Hypoaesthesia	46 (4.64%)
Paraesthesia Oral	37 (3.73%)
Anaesthetic Complication	22 (2.22%)
Dysgeusia	22 (2.22%)
Nerve Injury	21 (2.12%)
Dizziness	18 (1.82%)
Pain	18 (1.82%)
Ageusia	16 (1.61%)
Swelling Face	16 (1.61%)
	Show More
Burning Sensation	15 (1.51%)
Glossodynia	15 (1.51%)
Post Procedural Complication	14 (1.41%)
Nausea	13 (1.31%)
Anxiety	12 (1.21%)
Speech Disorder	12 (1.21%)
Tremor	10 (1.01%)
Dysphagia	9 (.91%)
Injection Site Pain	8 (.81%)
Loss Of Consciousness	8 (.81%)
Swelling	8 (.81%)
Dyspnoea	7 (.71%)
Fatigue	7 (.71%)
Blood Pressure Increased	6 (.61%)
Chest Pain	6 (.61%)
Convulsion	6 (.61%)
Dry Mouth	6 (.61%)
Headache	6 (.61%)
Hypogeusia	6 (.61%)
Lip Swelling	6 (.61%)
Swollen Tongue	6 (.61%)
Tongue Disorder	6 (.61%)
Trismus	6 (.61%)
Disorientation	5 (.5%)
Dysaesthesia	5 (.5%)
Facial Pain	5 (.5%)
Gingival Disorder	5 (.5%)
Heart Rate Increased	5 (.5%)
Hypoaesthesia Facial	5 (.5%)
Jaw Disorder	5 (.5%)
Muscle Tightness	5 (.5%)
Pallor	5 (.5%)
Palpitations	5 (.5%)
Urticaria	5 (.5%)
Amnesia	4 (.4%)
Angioedema	4 (.4%)
Asthenia	4 (.4%)
Confusional State	4 (.4%)
Erythema	4 (.4%)
Heart Rate Decreased	4 (.4%)
Hypertension	4 (.4%)
Incorrect Route Of Drug Administrat...	4 (.4%)
Malaise	4 (.4%)
Memory Impairment	4 (.4%)
Muscle Contractions Involuntary	4 (.4%)
Nervousness	4 (.4%)
Pain In Jaw	4 (.4%)
Restlessness	4 (.4%)
Syncope	4 (.4%)
Anaphylactic Reaction	3 (.3%)
Anosmia	3 (.3%)
Blister	3 (.3%)
Bone Disorder	3 (.3%)
Bronchospasm	3 (.3%)
Chills	3 (.3%)
Cold Sweat	3 (.3%)
Contraindication To Medical Treatme...	3 (.3%)
Contusion	3 (.3%)
Delayed Recovery From Anaesthesia	3 (.3%)
Discomfort	3 (.3%)
Drug Effect Prolonged	3 (.3%)
Drug Hypersensitivity	3 (.3%)
Drug Ineffective	3 (.3%)
Drug Interaction	3 (.3%)
Exophthalmos	3 (.3%)
Fear	3 (.3%)
Feeling Abnormal	3 (.3%)
Feeling Hot	3 (.3%)
Gingival Pain	3 (.3%)
Hypersensitivity	3 (.3%)
Iatrogenic Injury	3 (.3%)
Medication Error	3 (.3%)
Myalgia	3 (.3%)
Oedema Mouth	3 (.3%)
Oral Discomfort	3 (.3%)
Oral Pain	3 (.3%)
Retinal Vein Occlusion	3 (.3%)
Thinking Abnormal	3 (.3%)
Tooth Disorder	3 (.3%)
Vision Blurred	3 (.3%)
Vocal Cord Paralysis	3 (.3%)
Vomiting	3 (.3%)
Abdominal Discomfort	2 (.2%)
Alopecia	2 (.2%)
Arrhythmia	2 (.2%)
Blindness	2 (.2%)
Blindness Unilateral	2 (.2%)
Blood Pressure Decreased	2 (.2%)
Chest Discomfort	2 (.2%)
Diarrhoea	2 (.2%)

Share/Embed Graph Export Data

This graph shows the top adverse events submitted to the FDA for Septocaine, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Septocaine is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Septocaine

What are the most common Septocaine adverse events reported to the FDA?

Neurological	233 (23.51%)
Oral Soft Tissue Conditions	126 (12.71%)
Procedural And Device Related Injur...	47 (4.74%)
Epidermal And Dermal Conditions	34 (3.43%)
Tongue Conditions	31 (3.13%)
Gastrointestinal Signs	28 (2.83%)
Injuries	27 (2.72%)
Respiratory	22 (2.22%)
Cardiac And Vascular Investigations	20 (2.02%)
Anxiety Disorders	19 (1.92%)
Muscle	17 (1.72%)
	Show More
Medication Errors	16 (1.61%)
Administration Site Reactions	15 (1.51%)
Dental And Gingival Conditions	15 (1.51%)
Movement Disorders	15 (1.51%)
Cranial Nerve Disorders	14 (1.41%)
Bone Disorders	13 (1.31%)
Therapeutic And Nontherapeutic Effe...	13 (1.31%)
Mental Impairment	12 (1.21%)
Allergic Conditions	11 (1.11%)
Angiedema And Urticaria	9 (.91%)
Deliria	9 (.91%)
Salivary Gland Conditions	8 (.81%)
Vision	8 (.81%)
Lifestyle Issues	7 (.71%)
Musculoskeletal And Connective Tiss...	7 (.71%)
Neuromuscular	7 (.71%)
Cardiac Disorder Signs	6 (.61%)
Headaches	6 (.61%)
Seizures	6 (.61%)
Skin Appendage Conditions	6 (.61%)
Vascular	6 (.61%)
Chemical Injury And Poisoning	5 (.5%)
Retina, Choroid And Vitreous Hemorr...	5 (.5%)
Cardiac Arrhythmias	4 (.4%)
Changes In Physical Activity	4 (.4%)
Disturbances In Thinking	4 (.4%)
Inner Ear And Viiith Cranial Nerve	4 (.4%)
Tissue	4 (.4%)
Vascular Hypertensive	4 (.4%)
Bronchial Disorders	3 (.3%)
Infections - Pathogen Unspecified	3 (.3%)
Ocular Structural Change, Deposit A...	3 (.3%)
Skin And Subcutaneous Tissue	3 (.3%)
Upper Respiratory Tract Disorders	3 (.3%)
Aural	2 (.2%)
Body Temperature Conditions	2 (.2%)
Decreased And Nonspecific Blood Pre...	2 (.2%)
Eating Disorders	2 (.2%)
Eye	2 (.2%)
Fungal Infectious	2 (.2%)
Gastrointestinal Motility And Defec...	2 (.2%)
Head And Neck Therapeutic Procedure...	2 (.2%)
Immunology And Allergy	2 (.2%)
Sleep Disorders	2 (.2%)
Therapeutic Procedures And Supporti...	2 (.2%)
Toxicology And Therapeutic Drug Mon...	2 (.2%)
Arteriosclerosis, Stenosis, Vascula...	1 (.1%)
Central Nervous System Vascular	1 (.1%)
Communication Disorders	1 (.1%)
Coronary Artery	1 (.1%)
Embolism And Thrombosis	1 (.1%)
Encephalopathies	1 (.1%)
Glucose Metabolism Disorders	1 (.1%)
Injuries By Physical Agents	1 (.1%)
Joint	1 (.1%)
Metabolic And Nutritional Disorders...	1 (.1%)
Microbiology And Serology	1 (.1%)
Middle Ear Disorders	1 (.1%)
Mood Disorders	1 (.1%)
Nervous System, Skull And Spine The...	1 (.1%)
Ocular Hemorrhages And Vascular	1 (.1%)
Ocular Infections, Irritations And ...	1 (.1%)
Ocular Neuromuscular	1 (.1%)
Ocular Sensory Symptoms	1 (.1%)
Personality Disorders	1 (.1%)
Physical Examination Topics	1 (.1%)
Product Quality Issues	1 (.1%)
Psychiatric And Behavioural Symptom...	1 (.1%)
Skin Vascular Abnormalities	1 (.1%)
Spleen, Lymphatic And Reticulendoth...	1 (.1%)

Share/Embed Graph Export Data

This graph shows the top categories of adverse events submitted to the FDA for Septocaine, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Septocaine is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.